EDP-239

Novartis drops out of hep C race, punting a $440M Enanta pact
Fierce Biotech
Wed, 10/1/14 - 09:19 am
Novartis
hepatitis C
Enanta Pharmaceuticals
EDP-239
alisporivir
Enanta partners with Novartis to develop new drug to treat hepatitis C virus
Boston Globe, MA
Tue, 02/21/12 - 09:36 am
Novartis
Enanta
hepatitis C
EDP-239